Navigation Links
Avant's Typhoid Fever Vaccine Demonstrates Excellent Clinical,Potential

in AVANT's other press releases and filings with the Securities and Exchange Commission, from time to time. You should carefully review all of these factors, and you should be aware that there may be other factors that could cause these differences. These forward-looking statements were based on information, plans and estimates at the date of this press release, and AVANT does not promise to update any forward-looking statements to reflect changes in underlying assumptions or factors, new information, future events or other changes.

Contact

AVANT Immunotherapeutics, Inc.
Una S. Ryan, Ph.D., 781-433-0771
President and CEO
or
AVANT Immunotherapeutics, Inc.
Avery W. Catlin, 781-433-0771
Chief Financial Officer
info@avantimmune.com
or
For Media:
Kureczka/Martin Associates
Joan Kureczka, 415-821-2413
jkureczka@comcast.net


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Avant’s Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential
2. SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193
3. Placebo-controlled Phase IIa Study with the Immunotherapeutic CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in Hay Fever Patients
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
6. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
7. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
8. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
9. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
10. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
11. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference

Post Your Comments:
(Date:11/9/2009)..., SOUTH SAN FRANCISCO, Calif., Nov. 9 /PRNewswir...ay announced that on November 5, 2009, it received...q") stating that the Nasdaq Hearing Panel has gran... NASDAQ Global Market subject to the condition tha...er 31, 2009, the proposed merger (the "Merger") co...
(Date:11/8/2009)..., AARP Praises House Passage of Health Care Ref...then Medicare, improve coverage for all Americans ...re/ -- Today the United States House of Representa...on that would strengthen Medicare for seniors and ...ces millions of Americans out of affordable health...
(Date:11/6/2009)..., DURHAM, N.C., Nov. 6 ... OXBO) today announced that a previously approved ... at the start of trading on Monday, Nov. 9, 2009 o...peutics, Inc. shares will trade under the new symb...er, 69207P 20 9, when the split becomes effective....
Breaking Medicine Technology:Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 2Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 3AARP Idaho Key Vote News Alert 2AARP Idaho Key Vote News Alert 3Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3New cancer drug test promises safer and more effective clinical trials 10053 1New cancer drug test promises safer and more effective clinical trials 10053 2New cancer drug test promises safer and more effective clinical trials 10053 3Ultrasound can predict tumor burden and survival in melanoma patients 58115 1Ultrasound can predict tumor burden and survival in melanoma patients 58115 2Ultrasound can predict tumor burden and survival in melanoma patients 58115 3Mountain Home Helps Companies Battle Tough Economic Times by Offering Free Lean Six Sigma Training 58111 1Mountain Home Helps Companies Battle Tough Economic Times by Offering Free Lean Six Sigma Training 58111 2
...r to Demonstrate Significant Survival Benefit in,L...FirstCall/ -- Bayer,HealthCare Pharmaceuticals Inc...hat Nexavar(R) (sorafenib) tablets significantly,e...llular carcinoma,(HCC), or primary liver cancer ve...=0.0006). Results were presented at the 43rd,annua...
...--(BUSINESS WIRE)--Jun 4, 2007 - GenVec, Inc.,(Nas...y safety and,efficacy data from the clinical devel...s presented in a poster session on,gastrointestina...y,for Clinical Oncology in Chicago, IL by Dr. Mitc... discussion of the posters then,concluded the Satu...
Other Medicine Technology:Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 2Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 3Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 4Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 6Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 7GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 2GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 3GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 4
(Date:11/9/2009)...-- For the third consecutive year, the Barbara Ann... preferred hospital for cancer care in southeast M...earch Corporation. ,, (Logo: http://www.news..., The annual survey was conducted through an email...009. Survey respondents were the primary healthcar...
(Date:11/9/2009)..., however , , MONDAY, Nov. 9 (HealthDa...se breasts have a higher risk of cancer recurrence...reast density has already been linked with an incr...s have suspected that very dense breasts may also ...urrence at the site of the original cancer after l...
(Date:11/9/2009)...ewswire/ -- New Mayo Clinic research has found tha...cally reduces patient hospital stay and recovery t...at the North Central Section of the American Urolo...o: http://www.newscom.com/cgi-bin/prnh/20090105/... and video resources, including excerpts from an i...
(Date:11/9/2009)...re for Preteen Son - ,, PHILADELPHIA, Nov. 9 ... with cancer, the hopeful news is that pediatric s...Among the bad news -- treatments that enable survi...d with cancer who have reached puberty currently h...fore undergoing cancer treatment, they may have th...
(Date:11/9/2009)... WHAT: All PETCO stores nationwide will host a...ated by specially trained in-store nutrition, .... During the 30-minute, workshop, pe...f, their dogs and cats, have a chance... nutrition, receive an assessment of their individ...
Breaking Medicine News(10 mins):Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 2Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 4
...try,s Leading Study Tool to Expand Profile with Ar... Prep, the massage,industry,s leading study progra... massage school graduates. Beginning in 2008, Area... Prep guarantees passage of the rigorous NCETM and...
...sing Fourth Quarter & Full-Year 2007 Financial Res... 11, 2008, Presenting at the UBS Global Healthcar... February 12, 2008, CINCINNATI, Jan. 28 ... community events., Fourth Quarter & Full-Year 20...
...e number of Russian women who smoke has more than ...cording to new research. , In 1992, seven per cen...by 2003. In the same period, the number of men who...on of the previously state owned tobacco industry ...
...w York, New York The Cancer Research Institute (C...he Cancer Vaccine Consortium, a program of the Sab...borative, a program of the Cancer Research Institu...ed voice in the cancer vaccine field and provides ...
...LE, Jan. 28 Results from Milliman,s third annual,... U.S. variable annuity,(VA) carriers indicate that...some form of GLB., Total sales of VAs that offere...up to 95% during the first,half of 2007, demonstra...
...DO, Fla., Jan. 28 MEDai, Inc., headquartered in,O...hcare solutions,announced that its longstanding Pi... Diego, CA, was awarded the 2007 Malcolm Baldrige ...ce. Congress,established the program in 1987 to re...
Other Medicine News:Health News:Massage Prep(TM) Announces Outreach Program 2Health News:LCA-Vision Announces Upcoming Investment Community Events 2Health News:Number of Russian women smokers has doubled since Soviet collapse 2Health News:Cancer Vaccine Consortium and Cancer Vaccine Collaborative unite under the Cancer Research Institute 2Health News:Cancer Vaccine Consortium and Cancer Vaccine Collaborative unite under the Cancer Research Institute 3Health News:Milliman Survey Confirms Continued Dominance of Guarantees in Variable Annuity Retirement Income Products 2Health News:Milliman Survey Confirms Continued Dominance of Guarantees in Variable Annuity Retirement Income Products 3Health News:MEDai Client Named Recipient of 2007 Malcolm Baldrige National Quality Award 2Health News:MEDai Client Named Recipient of 2007 Malcolm Baldrige National Quality Award 3
Human Growth Hormone EIA Endocrine Function 025-BC-1033
...of pancreatic b-cell function is not only of use i...l history of diabetes mellitus, but is also releva...choice of treatment. Peripheral insulin levels ca... the large and variable uptake from the portal cir...
Anti-Gliadin IgG & IgA (Ab) EIA Gastrointestinal Markers 027-GD77 Celiac Disease Food Allergy
...n enzymeimmunoassay for the quantitation of 25-OH ...lasma. Calibrators, controls and samples are dilut...es are incubated in microtitre wells which are coa...for 2 hours at room temperature before aspiration ...
Medicine Products: